Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,707.35
(
1.13%
)
US TECH 100
24,060.80
(
1.31%
)
Dow Jones
47,005.33
(
0.96%
)
Brent Oil
97.84
(
-3.35%
)
Bitcoin
74,303.35
(
2.05%
)
News Focus
News Focus
Post# of 257246
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122788
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 68083

Saturday, 11/01/2008 9:59:59 AM

Saturday, November 01, 2008 9:59:59 AM

Post# of 257246
Now that’s what I call a timely post! Thanks.

p.s. I don't understand how this drug can be considered "first in class" when it clearly isn't the first NS5A inhibitor to be tested.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now